Sort
8,912 grants matching “sars cov 2”
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies
$21,360,749Lawrence Corey · Fred Hutchinson Cancer Research Center · S10 · FY2021 · AI
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE DELIVERABLE DUE DATES FOR RADX TECH PROJECT 2200
$21,300,000Wally Narajowski · · N02 · FY2021 · HL
The Role Of Subclinical Infection And Cytokines In Preterm Parturition
$21,083,739Roberto Romero · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
CoVPN 3008, Multi-Center, Randomized, Efficay Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$21,074,900Myron S Cohen · Family Health International · UM1 · FY2021 · AI
ACTIV-6
$20,600,000Daniel K Benjamin · Duke University · U24 · FY2022 · TR
RADx-UP CDCC
$20,162,334Michael Cohen-Wolkowiez · Duke University · U24 · FY2020 · MD
CoVPN 3502 / ACTIV-2/A5401
$19,807,516Judith S. Currier · University Of California Los Angeles · UM1 · FY2021 · AI
RADX TECH PROJECT #2620 ACCELERATED MANUFACTURING SCALE-UP FOR ANP TECHNOLOGIES' NANO-INTELLIGENT DETECTION SYSTEM(NIDS)COVID-19 ANTIGEN RAPID TEST
$19,727,817Greg Witham · Anp Technologies, Inc. · N02 · FY2021 · HL
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$19,404,520Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
UTMB-Novartis Alliance for Pandemic Preparedness
$18,849,015Vineet D Menachery · University Of Texas Med Br Galveston · U19 · FY2023 · AI
Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Multisystem Inflammatory Syndrome in Children (MIS-C) long-term follow-up
$18,781,641Gina Montealegre · Leidos Biomedical Research, Inc. · N01 · FY2021 · AI
CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older SDMC
$18,322,345Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
ON BEHALF OF DCR FACILITATE THE CONDUCT OF AN OBSERVATIONAL STUDY TO CHARACTERIZE PATIENTS WITH COVID-19 INFECTION (10,000 SUBJECTS).
$18,109,529Beth Baseler · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Design and Development of a Pan-betacoronavirus Vaccine
$17,521,953Barton F Haynes · Duke University · P01 · FY2021 · AI
ACME POCT EMERGENCY COVID-19 VARIANT TESTING & INDEPENDENT TEST ASSESSMENT EVALUATION SUPPLEMENT
$15,864,683Wilbur A Lam · Emory University · U54 · FY2022 · EB
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
$15,843,849Gloria David · Rho Federal Systems Division, Inc. · UM2 · FY2021 · AI
Emergency COVID-19 Variant Supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)
$15,481,896Wilbur A Lam · Emory University · U54 · FY2022 · EB
Vaccination for Recovered Inpatients with COVID-19 (VATICO)
$15,147,252Laura McNay · Leidos Biomedical Research, Inc. · N01 · FY2021 · AI
EXERCISE OPTION PERIOD 1 TO PROVIDE SUPPORT FOR TECHNICAL ASSESSMENTS AND PROJECT MANAGEMENT FOR THE NIBIB RAPID ACCELERATION OF DIAGNOSTICS (RADX) IN
$14,996,149Mark Marino · Venturewell · N02 · FY2021 · HL
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Lab
$14,980,054Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
EXERCISE OPTION PERIOD 2 TO PROVIDE SERVICES IN SUPPORT OF NIBIB COVID-19 RADX PROJECT FOR THE PERIOD 10/16/2021 - 01/31/2022
$14,871,886Elias Caro · · N02 · FY2021 · HL
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$14,844,618Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Translation Accelerator Core
$14,783,804Kevin V Grimes · Stanford University · U19 · FY2022 · AI
Core C: Medicinal Chemistry and DMPK
$13,141,857Thomas D Bannister · University Of Minnesota · U19 · FY2022 · AI
Washington National Primate Research Center
$12,987,645Mari Ostendorf · University Of Washington · P51 · FY2024 · OD